These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27746582)

  • 21. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
    Liu B; Yu X; Luo K; Yu Y; Yu XF
    J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insertion of host-derived costimulatory molecules CD80 (B7.1) and CD86 (B7.2) into human immunodeficiency virus type 1 affects the virus life cycle.
    Giguère JF; Bounou S; Paquette JS; Madrenas J; Tremblay MJ
    J Virol; 2004 Jun; 78(12):6222-32. PubMed ID: 15163715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles.
    Fitzpatrick K; Skasko M; Deerinck TJ; Crum J; Ellisman MH; Guatelli J
    PLoS Pathog; 2010 Mar; 6(3):e1000701. PubMed ID: 20221443
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag.
    Ahi YS; Yimer D; Shi G; Majdoul S; Rahman K; Rein A; Compton AA
    mBio; 2020 Jan; 11(1):. PubMed ID: 31964738
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New insights into the functionality of a virion-anchored host cell membrane protein: CD28 versus HIV type 1.
    Giguère JF; Paquette JS; Bounou S; Cantin R; Tremblay MJ
    J Immunol; 2002 Sep; 169(5):2762-71. PubMed ID: 12193751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.
    O'Doherty U; Swiggard WJ; Malim MH
    J Virol; 2000 Nov; 74(21):10074-80. PubMed ID: 11024136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A virion-specific inhibitory molecule with therapeutic potential for human immunodeficiency virus type 1.
    Matsuda Z; Yu X; Yu QC; Lee TH; Essex M
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3544-8. PubMed ID: 7682710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The virion-associated Gag-Pol is decreased in chimeric Moloney murine leukemia viruses in which the readthrough region is replaced by the frameshift region of the human immunodeficiency virus type 1.
    Gendron K; Dulude D; Lemay G; Ferbeyre G; Brakier-Gingras L
    Virology; 2005 Apr; 334(2):342-52. PubMed ID: 15780884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
    Yao XJ; Kobinger G; Dandache S; Rougeau N; Cohen E
    Gene Ther; 1999 Sep; 6(9):1590-9. PubMed ID: 10490769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
    Aiken C; Trono D
    J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.
    Bounou S; Leclerc JE; Tremblay MJ
    J Virol; 2002 Feb; 76(3):1004-14. PubMed ID: 11773376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virion-Packaged Pyruvate Kinase Muscle Type 2 Affects Reverse Transcription Efficiency of Human Immunodeficiency Virus Type 1 by Blocking Virion Recruitment of tRNA
    Mouree KR; Kishimoto N; Iga N; Kirihara C; Yamamoto K; Takamune N; Misumi S
    Biol Pharm Bull; 2018; 41(4):612-618. PubMed ID: 29607934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneity of envelope molecules expressed on primary human immunodeficiency virus type 1 particles as probed by the binding of neutralizing and nonneutralizing antibodies.
    Poignard P; Moulard M; Golez E; Vivona V; Franti M; Venturini S; Wang M; Parren PW; Burton DR
    J Virol; 2003 Jan; 77(1):353-65. PubMed ID: 12477840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.
    Wu X; Liu H; Xiao H; Conway JA; Kappes JC
    J Virol; 1996 Jun; 70(6):3378-84. PubMed ID: 8648668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycosyl-Phosphatidylinositol-Anchored Anti-HIV Env Single-Chain Variable Fragments Interfere with HIV-1 Env Processing and Viral Infectivity.
    Misra A; Gleeson E; Wang W; Ye C; Zhou P; Kimata JT
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between virion-bound host intercellular adhesion molecule-1 and the high-affinity state of lymphocyte function-associated antigen-1 on target cells renders R5 and X4 isolates of human immunodeficiency virus type 1 more refractory to neutralization.
    Fortin JF; Cantin R; Bergeron MG; Tremblay MJ
    Virology; 2000 Mar; 268(2):493-503. PubMed ID: 10704357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporation of functional human immunodeficiency virus type 1 integrase into virions independent of the Gag-Pol precursor protein.
    Liu H; Wu X; Xiao H; Conway JA; Kappes JC
    J Virol; 1997 Oct; 71(10):7704-10. PubMed ID: 9311854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interference with the production of infectious viral particles and bimodal inhibition of replication are broadly conserved antiviral properties of IFITMs.
    Tartour K; Nguyen XN; Appourchaux R; Assil S; Barateau V; Bloyet LM; Burlaud Gaillard J; Confort MP; Escudero-Perez B; Gruffat H; Hong SS; Moroso M; Reynard O; Reynard S; Decembre E; Ftaich N; Rossi A; Wu N; Arnaud F; Baize S; Dreux M; Gerlier D; Paranhos-Baccala G; Volchkov V; Roingeard P; Cimarelli A
    PLoS Pathog; 2017 Sep; 13(9):e1006610. PubMed ID: 28957419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human immunodeficiency virus type I Nef independently affects virion incorporation of major histocompatibility complex class I molecules and virus infectivity.
    Le Gall S; Prevost MC; Heard JM; Schwartz O
    Virology; 1997 Mar; 229(1):295-301. PubMed ID: 9123874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.